Replies to post #405082 on Amarin Corp Plc (AMRN)

[Whalatane]

Zip. with all due respect

This post-hoc analysis showed that icosapent ethyl (IPE) substantially and significantly reduced the risk of first and total ischemic events by 37% and 36% respectively in patients with recent acute coronary syndrome (ACS) without increasing bleeding, supporting early initiation of IPE after ACS.

If Health providers / Insurers / Cardiologists believed these numbers they would have no problem prescribing and paying for ( at current cost ) Vascepa for these patients

Just do the numbers
Do you know the costs of a PCI etc now
Prescribing Vascepa for these patients would be a HUGE cost savings in future costs ...if they believed the numbers
Kiwi